2026 NPPES data Cornea and External Diseases Specialist Physician NPI 1619465374
Verify on CMS →

JORDAN COMSTOCK

Cornea and External Diseases Specialist Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
213
Medicare Part D claims · 92 beneficiaries · Cornea and External Diseases Specialist Physician avg: 1K
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.059/100
▲ 1 pts above national avg 83.1 · [object Object]
Industry payments
$569.76
13 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: JORDAN COMSTOCK is a Cornea and External Diseases Specialist Physician ([object Object]) practicing in DALLAS, Texas with a Medicare Part D prescribing footprint of 213 claims across 92 beneficiaries — 44% brand-name prescribing . Their CMS MIPS Final Score of 84.059/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $569.76 across 13 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: JORDAN COMSTOCK reported a CMS MIPS final score of 84.059 out of 100, above the 83.1 national average, and filed 213 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

JORDAN COMSTOCK practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

JORDAN COMSTOCK at a glance

Near national average

NPI registry status

Active

Issued 04/27/2018

NPI 1619465374

Primary specialty

Cornea and External Diseases Specialist Physician

Rare

294 US NPIs in this specialty

Medicare Part D claims

213 83% vs specialty avg

2023 prescription claims

Specialty avg: 1,232

MIPS final score

84.059/100 0.9590000000000032% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Cornea and External Diseases Specialist Physician compares to other specialties among Texas providers

Texas providers

Cornea and External Diseases Specialist Physician share within Texas

1. Cornea and External Diseases Specialist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cornea and External Diseases Specialist Physician share within Texas

Medicare quality performance — MIPS

JORDAN COMSTOCK's 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average

Near national average
MIPS Final Score
84.059/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cornea and External Diseases Specialist Physician) — 84.059/100 vs national avg 83.1

0%100%National avg83%84.1%
MIPS final score (Cornea and External Diseases Specialist Physician) — 84.059/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JORDAN COMSTOCK is a Cornea and External Diseases Specialist Physician provider practicing in DALLAS, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1619465374. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JORDAN COMSTOCK appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider at 10740 N CENTRAL EXPY STE 350, DALLAS, TX, 75231, with a listed phone of (214) 692-0146. NPI 1619465374 was issued on 04/27/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what COMSTOCK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 213 prescription claims written by this provider, covering 92 Medicare beneficiaries and totaling roughly $36K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.059/100 for the 2023 performance year (Quality 84.4904, Cost 54.3968), compared with the national average of 83.1.

Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10740 N CENTRAL EXPY STE 350
DALLAS, TX 75231

Provider Details

NPI 1619465374
Specialty Cornea and External Diseases Specialist Physician
Gender Female
NPI Issued 04/27/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

84.059
Final Score
Avg: 83.1
84.4904
Quality
54.3968
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where JORDAN COMSTOCK bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CORNEA ASSOCIATES OF TEXAS PA
PLANO, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JORDAN COMSTOCK. Source: openpaymentsdata.cms.gov.

Total received

$570

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JORDAN COMSTOCK. To verify JORDAN COMSTOCK's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JORDAN COMSTOCK — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 213 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

213
Total Claims
$36K
Total Drug Cost
92
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
282
Total Day Supply
6,767
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$30K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.31
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Moxifloxacin
Moxifloxacin Hcl
59
Prednisolone Acetate
48
Restasis
Cyclosporine
14
Brimonidine Tartrate
12
Loteprednol Etabonate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cornea and External Diseases Specialist Physician Overview

How JORDAN COMSTOCK fits within the Cornea and External Diseases Specialist Physician landscape nationally.

294
Cornea and External Diseases Specialist Physician Providers in US
43
States with Cornea and External Diseases Specialist Physician
1,232
Avg Claims per Provider

JORDAN COMSTOCK's 213 claims are below the specialty average of 1,232.

Nearby Cornea and External Diseases Specialist Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as COMSTOCK.

Compare Cornea and External Diseases Specialist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JORDAN COMSTOCK's specialty?
JORDAN COMSTOCK specializes in Cornea and External Diseases Specialist Physician and practices in DALLAS, Texas.
How much does JORDAN COMSTOCK prescribe under Medicare Part D?
In 2023, JORDAN COMSTOCK wrote 213 Medicare Part D claims totaling $36K in drug costs for 92 beneficiaries.
What is JORDAN COMSTOCK's Medicare quality score?
JORDAN COMSTOCK has a CMS MIPS Final Score of 84.059/100 (Quality: 84.4904, Cost: 54.3968). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JORDAN COMSTOCK located?
JORDAN COMSTOCK is located at 10740 N CENTRAL EXPY STE 350, DALLAS, TX, 75231. Phone: (214) 692-0146.
What is JORDAN COMSTOCK's NPI number?
JORDAN COMSTOCK's National Provider Identifier (NPI) is 1619465374, issued on 04/27/2018.
Does JORDAN COMSTOCK prescribe more brand-name or generic drugs?
JORDAN COMSTOCK's prescribing is 44% brand-name and 56% generic drugs by claim count, with $30K in brand drug costs.
How many Cornea and External Diseases Specialist Physician providers are there in the US?
There are 294 Cornea and External Diseases Specialist Physician providers across 43 states in the US. The average Cornea and External Diseases Specialist Physician provider writes 1,232 Medicare Part D claims per year.
What drugs does JORDAN COMSTOCK prescribe most often?
Based on 2023 Medicare Part D data, JORDAN COMSTOCK's most frequently prescribed drugs include Moxifloxacin, Prednisolone Acetate, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JORDAN COMSTOCK accept Medicare?
JORDAN COMSTOCK appears in CMS Medicare data with 213 Part D claims and 92 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JORDAN COMSTOCK's credentials?
JORDAN COMSTOCK's NPI is 1619465374. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology